Talphera (TLPH) Other Non-Current Assets (2010 - 2022)

Talphera's (TLPH) quarterly Other Non-Current Assets came in at $1.9 million in Q4 2022, down 61.38% year-on-year from $5.0 million in Q4 2021, and up 669.32% quarter-over-quarter from $251000.0 in Q3 2022.

Talphera (TLPH) Other Non-Current Assets (2010 - 2022) Analysis & Trends

Talphera's Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $1.9 million for Q4 2022.

  • On a quarterly basis, Other Non-Current Assets fell 61.38% year-over-year to $1.9 million in Q4 2022; TTM through Dec 2022 was $1.9 million, a 61.38% decrease from a year earlier, with the FY2022 full-year figure at $1.9 million, down 61.38% from the prior year.
  • Other Non-Current Assets improved to $1.9 million in Q4 2022 per TLPH's latest filing, from $251000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $5.0 million in Q4 2020 and bottomed at $70000.0 in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $900000.0 (2019), against an average of $1.6 million.
  • Across the five-year window, Other Non-Current Assets soared 594.44% in 2021 and slumped 94.98% in 2022, its largest moves.
  • Year by year, Other Non-Current Assets stood at $705000.0 in 2018, then soared by 68.51% to $1.2 million in 2019, then jumped by 320.88% to $5.0 million in 2020, then changed by 0.0% to $5.0 million in 2021, then slumped by 61.38% to $1.9 million in 2022.
  • Per Business Quant, the three latest TLPH Other Non-Current Assets figures stand at $1.9 million (Q4 2022), $251000.0 (Q3 2022), and $261000.0 (Q1 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Talphera 47.31 Mn 9.48 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 1.93 Mn
Sep 30, 2022 251,000.00
Mar 31, 2022 261,000.00
Dec 31, 2021 5.00 Mn
Sep 30, 2021 5.00 Mn
Jun 30, 2021 5.00 Mn
Mar 31, 2021 70,000.00
Dec 31, 2020 5.00 Mn
Sep 30, 2020 720,000.00
Jun 30, 2020 784,000.00
Mar 31, 2020 902,000.00
Dec 31, 2019 1.19 Mn
Sep 30, 2019 984,000.00
Jun 30, 2019 1.02 Mn
Mar 31, 2019 900,000.00
Dec 31, 2018 705,000.00
Sep 30, 2018 178,000.00
Jun 30, 2018 178,000.00
Mar 31, 2018 178,000.00
Dec 31, 2017 207,000.00